Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> CARDIOVASCULAR DISEASE Latest News

JUL 21, 2013 - MedPage Today

A Must Read - Share

Study Clears Avandia of Fatal Cardiac Events (CME/CE)

(MedPage Today) -- The controversial diabetes drug rosiglitazone (Avandia) won't increase the risk of major cardiovascular events and mortality in diabetic patients who have established coronary artery disease (CAD), researchers found.

Tags: Study Clears Avandia of Fatal Cardiac Events (CME/CE),  Cardiovascular Disease Latest News